Quick Answer
Pharmagreen Biotech Inc. reported R&D Expense of $4.0 thousand for fiscal year 2019.
Pharmagreen Biotech Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2019 | $4.0K | -48.1% |
| 2018 | $7.6K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| June 30, 2019 | -$32.7K | — | -574.1% |
| March 31, 2019 | $6.9K | — | -76.8% |
| December 31, 2018 | $29.7K | — | — |
- Pharmagreen Biotech Inc. showed a decrease of -48.1% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2019 period, Pharmagreen Biotech Inc.’s r&d expense has declined by 48.1% (from $7.6 thousand to $4.0 thousand).
- The most recent figure is from Pharmagreen Biotech Inc.’s fiscal year 2020 report (Form 10-K), filed with the SEC on January 8, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: